November 16, 2022
  • November 16, 2022

Salonpas (R) launches website for healthcare professionals

By on August 9, 2021 0

FLORHAM PARK, NJ / ACCESSWIRE / August 9, 2021 / Hisamitsu America today announced that Salonpas®, the # 1 physician-recommended pain reliever patch brand in the United States *, has launched, a site exclusively reserved for healthcare professionals. includes information on all Salonpas products as well as clinical studies and comments from key opinion leaders. The new website also offers samples and product support materials for healthcare professionals who sign up.

Salonpas® offers a complete line of patches, creams, roll-ons, gels and sprays that use a variety of active ingredients, formulas and technologies. Salonpas patches include:

The Salonpas Wallet provides temporary relief from minor muscle and joint pain associated with arthritis, simple back pain, sprains, bruises and strains.

Information on product samples, clinical studies and guidelines offers samples, clinical studies, and guideline information, all of which are useful to healthcare professionals.

“Providing healthcare professionals with clinical evidence, product information and product samples supports their recommendation for treatment for patients with pain. The healthcare professional’s recommendations ensure that people with pain have access to safe and effective over-the-counter topical pain relievers, ”said John Incledon, president of Hisamitsu. America, the distributors of Salonpas®, the world’s leading brand of over-the-counter pain patches.

The trend of increasing recommendations for topical pain relievers follows a growing body of guidance and recommendations from leading medical authorities. In guidelines released in August 2020, the American College of Physicians (ACP) and the American Academy of Family Physicians (AAFP) recommend the use of topical nonsteroidal anti-inflammatory drugs (NSAIDs) as the first-line treatment for treatment of back pain due to musculoskeletal injuries in an outpatient setting. Previously, the Centers for Disease Control (CDC) published advice clinicians to consider topical pain relievers as the first-line treatment in response to the opioid crisis.

Support for the clinical study and expert advice also contains a number of clinical studies including a recent Pain Management Study titled, “Personalized Pain Therapy: Artificial Intelligence (AI) Used to Predict Patient Response to Over-the-Counter Topical Pain relievers.“It is based on data from the previously published RELEF study which investigated Salonpas Pain Relief Patch and found that patients treated with Salonpas reported greater reductions in pain severity, better quality of life, and less use of oral pain relievers than patients who were not treated with Salonpas. This study is published in Anesthesia & Research, an international peer-reviewed scientific journal. Healthcare professionals can access this study here.

In addition, reprints of the Higashi study, which led to the first FDA approval for an over-the-counter topical pain reliever, may also be demand.

Healthcare professionals visiting the site can access a question-and-answer session with Dr. Jeffrey Gudin, a esteemed pain management physician and Salonpas advisor who shares his ideas.

“For over 80 years, Salonpas has fulfilled its mission of improving the quality of people’s lives through topical pain relief products,” said Incledon. “Our family of patches, creams, roll-ons, gels and sprays are effective, readily available over the counter, safe and non-addictive. We call ‘good medicine’.”

About Hisamitsu America:

Hisamitsu America is the US division of Hisamitsu Pharmaceutical Co., Inc., founded in 1847, which has specialized in transdermal drug delivery system technology since the introduction of its Salonpas line of patches in 1934. The Salonpas® The product line, which gained rapid acceptance in Asia and is now registered in over 30 countries, pioneered the development of transdermal patches for pain relief. Since 2010, Salonpas has grown into one of the fastest growing OTC brands in the United States. Salonpas became the # 1 pain relief brand on Facebook in 2020. For more information,

* Source: IQVIA 2021

Media contact: Nancy Thompson, Vorticom, Inc. 212.532.2208 (o), 917.371.4053 (m);

THE SOURCE: Hisamitsu America

See the source version on–Product-Samples-Clinical-Study-Information-and-more-at-SalonpasProcom